Search results
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $2.4 per share a year ago. These figures
DarioHealth Q2 Earnings Call Highlights
Key Points
- Interested in DarioHealth Corp.? Here are five stocks we like better.
- Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Stock / Food & Drug Retailing / Large Cap /
Nobilis Health Corp.
WKN: A12GGN / Symbol: NRTSF / Name: Nobilis Health / Stock / Healthcare Providers & Services / Micro Cap /
Medx Health Corp.
WKN: A0YJHF / Name: Medx Health / Stock / Healthcare Equipment & Supplies / Micro Cap /
Danaos Corp
WKN: A2PH59 / Name: Danaos / Stock / Freight & Logistics Services / Small Cap /
Daihen Corp
WKN: 859037 / Name: Daihen / Stock / Machinery, Equipment & Components / Micro Cap /
EGF Theramed Health Corp.
WKN: A3DMEG / Name: EGF Theramed Health / Stock / Micro Cap /


